Dr. Norbert Moskovits, MD
NPI: 1497713879
Total Payments
$327,637
2024 Payments
$10,744
Companies
35
Transactions
627
Medicare Patients
9,485
Medicare Billing
$698,162
Payment Breakdown by Category
Other$300,931 (91.8%)
Food & Beverage$14,562 (4.4%)
Consulting$7,780 (2.4%)
Travel$4,105 (1.3%)
Education$258.52 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300,931 | 111 | 91.8% |
| Food and Beverage | $14,562 | 459 | 4.4% |
| Consulting Fee | $7,780 | 3 | 2.4% |
| Travel and Lodging | $4,105 | 44 | 1.3% |
| Education | $258.52 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $224,211 | 183 | $0 (2024) |
| Merck Sharp & Dohme LLC | $62,256 | 45 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $29,158 | 48 | $0 (2024) |
| Abbott Laboratories | $3,977 | 91 | $0 (2024) |
| CVRx, Inc. | $2,204 | 4 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $961.57 | 37 | $0 (2022) |
| PFIZER INC. | $908.36 | 33 | $0 (2024) |
| Amgen Inc. | $664.00 | 39 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $657.22 | 38 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $509.54 | 21 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,744 | 26 | Merck Sharp & Dohme LLC ($6,588) |
| 2023 | $32,577 | 53 | Merck Sharp & Dohme LLC ($25,162) |
| 2022 | $32,424 | 46 | Merck Sharp & Dohme LLC ($24,002) |
| 2021 | $17,519 | 57 | AstraZeneca Pharmaceuticals LP ($7,075) |
| 2020 | $13,480 | 56 | Novartis Pharmaceuticals Corporation ($6,823) |
| 2019 | $52,415 | 122 | Novartis Pharmaceuticals Corporation ($50,792) |
| 2018 | $71,182 | 108 | Novartis Pharmaceuticals Corporation ($69,711) |
| 2017 | $97,296 | 159 | Novartis Pharmaceuticals Corporation ($94,012) |
All Payment Transactions
627 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.99 | General |
| 11/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.05 | General |
| Category: Cardiovascular | ||||||
| 09/30/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Heart Failure | ||||||
| 09/30/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Heart Failure | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $30.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $32.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/18/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Heart Failure | ||||||
| 06/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.39 | General |
| 05/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,185.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $11.49 | General |
| 05/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Travel and Lodging | Cash or cash equivalent | $75.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/19/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Heart Failure | ||||||
| 04/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Travel and Lodging | Cash or cash equivalent | $75.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,185.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.37 | General |
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,848 | 4,124 | $649,764 | $194,744 |
| 2022 | 14 | 2,510 | 3,595 | $614,460 | $191,765 |
| 2021 | 14 | 2,135 | 3,081 | $483,890 | $165,902 |
| 2020 | 14 | 1,992 | 2,824 | $446,204 | $145,752 |
Total Patients
9,485
Total Services
13,624
Medicare Billing
$698,162
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 325 | 477 | $141,060 | $39,279 | 27.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 142 | 354 | $120,740 | $38,208 | 31.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 131 | 159 | $81,030 | $24,223 | 29.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 112 | 303 | $66,460 | $21,641 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 117 | 138 | $59,130 | $16,928 | 28.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,433 | 2,075 | $41,500 | $14,411 | 34.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 241 | 248 | $47,120 | $14,113 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 76 | 76 | $30,185 | $8,422 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 83 | 96 | $19,040 | $4,947 | 26.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 77 | 77 | $18,510 | $4,725 | 25.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 37 | $13,789 | $4,212 | 30.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 27 | 29 | $6,650 | $2,146 | 32.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 23 | $3,220 | $1,061 | 33.0% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 17 | 17 | $1,030 | $331.84 | 32.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 15 | 15 | $300.00 | $95.16 | 31.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 163 | 427 | $123,830 | $40,980 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 295 | 439 | $123,460 | $37,259 | 30.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 138 | 172 | $98,040 | $31,532 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 104 | 129 | $54,400 | $16,152 | 29.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 93 | 219 | $43,800 | $14,516 | 33.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 223 | 230 | $57,270 | $13,968 | 24.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 1,216 | 1,676 | $33,520 | $12,299 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 87 | 87 | $34,800 | $10,574 | 30.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 68 | 68 | $17,090 | $5,261 | 30.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 24 | 29 | $11,310 | $3,748 | 33.1% |
About Dr. Norbert Moskovits, MD
Dr. Norbert Moskovits, MD is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497713879.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Norbert Moskovits, MD has received a total of $327,637 in payments from pharmaceutical and medical device companies, with $10,744 received in 2024. These payments were reported across 627 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($300,931).
As a Medicare-enrolled provider, Moskovits has provided services to 9,485 Medicare beneficiaries, totaling 13,624 services with total Medicare billing of $698,162. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Other Specialties Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 05/03/2006
- Last Updated 10/11/2018
- Taxonomy Code 207RA0001X
- Entity Type Individual
- NPI Number 1497713879
Products in Payments
- ENTRESTO (Drug) $224,211
- VERQUVO (Drug) $58,605
- FARXIGA (Drug) $28,840
- Barostim Neo System (Device) $2,204
- Circulatory Support (Device) $2,172
- LifeVest (Device) $961.57
- ELIQUIS (Drug) $801.22
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $753.58
- XARELTO (Drug) $657.22
- Corlanor (Drug) $540.24
- HeartMate (Device) $480.06
- JARDIANCE (Drug) $420.83
- HeartMate 3 Left Ventricular Assist Device (Device) $322.71
- MULTAQ (Drug) $259.41
- Impella (Device) $175.00
- iFuse Implant (Device) $130.29
- Repatha (Biological) $123.76
- ZIO Patch (Device) $113.22
- PRALUENT ALIROCUMAB INJECTION (Biological) $110.48
- WATCHMAN (Device) $99.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Advanced Heart Failure and Transplant Cardiology Doctors in Brooklyn
Dr. Steven Sorci, Do, DO
Advanced Heart Failure and Transplant Cardiology — Payments: $14,116
Advanced Heart Failure and Transplant Cardiology $14,116
Dr. Danyaal Moin, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $4,819
Advanced Heart Failure and Transplant Cardiology $4,819